Good Clinical Responders to Topical Timolol in Patients with Infantile Hemangiomas: A 7-Year Retrospective Study of 328 Korean Patients

BACKGROUND: Topical timolol is widely used for treatment of superficial infantile hemangioma (IH). However, little is known about factors that affect the response to topical timolol treatment. OBJECTIVE: This study aimed to investigate the efficacy, safety, and predictive value for good response to...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Da-Ae, Min, Se Hee, Song, Jaeryong, Park, Jong Seo, Lee, Hanjae, Ohn, Jungyoon, Kim, Kyu Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561300/
https://www.ncbi.nlm.nih.gov/pubmed/36198627
http://dx.doi.org/10.5021/ad.21.203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561300/
https://www.ncbi.nlm.nih.gov/pubmed/36198627
http://dx.doi.org/10.5021/ad.21.203

Ejemplares similares